# Effectiveness and Safety of Rivaroxaban Used in Extended Anticoagulation for Pulmonary Embolism Patients

> **NCT04527042** · — · UNKNOWN · sponsor: **China-Japan Friendship Hospital** · enrollment: 496 (estimated)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT04527042
- **Lead sponsor:** China-Japan Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-30
- **Primary completion:** 2022-11-29
- **Final completion:** 2024-05-30
- **Target enrollment:** 496 (ESTIMATED)
- **Last updated:** 2020-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04527042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04527042, "Effectiveness and Safety of Rivaroxaban Used in Extended Anticoagulation for Pulmonary Embolism Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04527042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*